Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacobson

Showing results (61-70 of 19,044) with videos related to

Pageof 1,905
Sort By:
The Oncologist|March 29, 2022
Ribociclib Improves Overall Survival in HR+/HER2- Metastatic Breast Cancer Across Common Genomic and Clinical SubtypesAnne Jacobson
The Oncologist|March 29, 2022
Trastuzumab Deruxtecan Improves Progression-Free Survival and Intracranial Response in Patients with HER2-Positive Metastatic Breast Cancer and Brain MetastasesAnne Jacobson
The Oncologist|March 29, 2022
SABCS 2021 Insights on Breast Cancer Research: An Interview with Dr. Laura SpringAnne Jacobson
National Journal|August 8, 1994
A voice, at last, for America's caregiversL Jacobson
National Journal|June 11, 1996
Medicare's mixed bag of problemsL Jacobson
Food Management|January 8, 1995
Challenge: how to provide care for AIDS patientsS Jacobson
Adolescent Medicine (Philadelphia, Pa.)|October 1, 1996
Beware of Cloudy SerumKohn, Jacobson
National Journal|July 19, 1994
AIDS--mémoireL Jacobson
Business and Health|September 6, 1988
Employers zero in on future healthM Jacobson
Endocrinology|August 5, 1999
Lower weight loss and food intake in protein-deprived, corticotropin releasing hormone-deficient mice correlate with glucocorticoid insufficiencyL Jacobson
Pageof 1,905

Showing results (61-70 of 19,044) with videos related to

Sort By:
Pageof 1,905
The Oncologist|March 29, 2022
Ribociclib Improves Overall Survival in HR+/HER2- Metastatic Breast Cancer Across Common Genomic and Clinical SubtypesAnne Jacobson
The Oncologist|March 29, 2022
Trastuzumab Deruxtecan Improves Progression-Free Survival and Intracranial Response in Patients with HER2-Positive Metastatic Breast Cancer and Brain MetastasesAnne Jacobson
The Oncologist|March 29, 2022
SABCS 2021 Insights on Breast Cancer Research: An Interview with Dr. Laura SpringAnne Jacobson
National Journal|August 8, 1994
A voice, at last, for America's caregiversL Jacobson
National Journal|June 11, 1996
Medicare's mixed bag of problemsL Jacobson
Food Management|January 8, 1995
Challenge: how to provide care for AIDS patientsS Jacobson
Adolescent Medicine (Philadelphia, Pa.)|October 1, 1996
Beware of Cloudy SerumKohn, Jacobson
National Journal|July 19, 1994
AIDS--mémoireL Jacobson
Business and Health|September 6, 1988
Employers zero in on future healthM Jacobson
Endocrinology|August 5, 1999
Lower weight loss and food intake in protein-deprived, corticotropin releasing hormone-deficient mice correlate with glucocorticoid insufficiencyL Jacobson
Pageof 1,905